• Users Online: 258
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most popular articles (Since January 06, 2017)

 
 
  Archives   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEWS
The advances in targeted therapy and immunotherapy for glioblastoma: Basic research and clinical trials
Mei Wang, Xiaochun Jiang, Fubing Wu, Haojun Xu, Zihong Lin, Bin Qi, Hongping Xia
May-June 2018, 1(3):79-88
DOI:10.4103/glioma.glioma_10_18  
  2,539 397 -
Molecular mechanisms involved in angiogenesis and potential target of antiangiogenesis in human glioblastomas
Yang Xu, Fan-En Yuan, Qian-Xue Chen, Bao-Hui Liu
March-April 2018, 1(2):35-42
DOI:10.4103/glioma.glioma_10_17  
  1,708 320 -
Pediatric high-grade glioma: A heterogeneous group of neoplasms with different molecular drivers
Francesca Gianno, Manila Antonelli, Elisabetta Ferretti, Maura Massimino, Antonietta Arcella, Felice Giangaspero
July-August 2018, 1(4):117-124
DOI:10.4103/glioma.glioma_27_18  
  1,619 380 -
Current concepts of imaging genomics in glioma
Ru-Jia Wang, Gui-Quan Shen, Mark S Shiroishi, Bo Gao
January-February 2018, 1(1):9-15
DOI:10.4103/glioma.glioma_1_18  
  1,577 352 -
Histological approach to neuronal and mixed neuronal-glial tumors of the central nervous system
Char Loo Tan, Roger E McLendon
May-June 2018, 1(3):89-96
DOI:10.4103/glioma.glioma_24_18  
  1,426 264 1
Engineered T Cells for glioblastoma therapy
Junjie Zhong, Jianhong Zhu
July-August 2018, 1(4):125-131
DOI:10.4103/glioma.glioma_26_18  
  1,256 261 -
ORIGINAL ARTICLES
Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
Matthieu Dreyfus, Michèle El-Atifi, Magali Court, Marie Bidart, Charles Coutton, Céline Leclech, Bruno Ballester, Emmanuel Garcion, Ali Bouamrani, François Berger, Didier Wion
March-April 2018, 1(2):66-78
DOI:10.4103/glioma.glioma_3_18  
  1,229 169 -
REVIEWS
Myeloid-derived suppressor cells and nonresolving inflammatory cells in glioma microenvironment: molecular mechanisms and therapeutic strategies
Xiao-Yan Ji, Jia-Wei Ma, Jun Dong
January-February 2018, 1(1):2-8
DOI:10.4103/glioma.glioma_2_17  
  1,165 211 -
ORIGINAL ARTICLES
Vasculogenic mimicry persists during glioblastoma xenograft growth
Cong Li, Yin-Sheng Chen, Qing-Ping Zhang, Jian-Liang Chen, Jing Wang, Fu-Rong Chen, Ho-Keung N G, Zhong-Ping Chen
January-February 2018, 1(1):16-21
DOI:10.4103/glioma.glioma_4_17  
  1,106 175 -
REVIEWS
Angiogenesis in glioma
Fei-Yi-Fan Wang, Xue-Jun Li
March-April 2018, 1(2):43-49
DOI:10.4103/glioma.glioma_9_18  
  1,072 204 -
How does one do next-generation sequencing for brain tumors in the clinical laboratories?
Kay Ka-Wai Li, Ho-Keung Ng
September-October 2018, 1(5):149-154
DOI:10.4103/glioma.glioma_36_18  
  1,053 218 -
Ongoing evolution of response assessment in glioma: Where do we stand?
Li Yi, Haolang Ming, Shengping Yu, Bingcheng Ren, Xuejun Yang
May-June 2018, 1(3):97-103
DOI:10.4103/glioma.glioma_13_18  
  1,042 185 -
Advances in exosome-related biomarkers for glioblastoma: Basic research and clinical application
Yuzhen Jiang, Jiaying Qian, Jun Yang, Xiaoling Yan, Xiaoying Xue, Qing Chang
September-October 2018, 1(5):159-167
DOI:10.4103/glioma.glioma_35_18  
  1,002 225 -
ORIGINAL ARTICLES
In vitro therapy against glioblastoma cells by 3-Dezaneplanocin-A, panobinostat, and temozolomide
Javier de la Rosa, Alejandro Urdiciain, Bárbara Meléndez, Juan A Rey, Miguel A Idoate, Javier S Castresana
January-February 2018, 1(1):22-26
DOI:10.4103/glioma.glioma_6_18  
  925 161 -
Correlation of conventional magnetic resonance imaging features with O6-methylguanine-DNA-methyltransferase gene promoter methylation status and survival outcomes in patients with newly diagnosed glioblastoma: Single-center correlative imaging substudy from a prospective clinical trial
Tejpal Gupta, Anil Tibdewal, Sarthak Mohanty, Torsten Pietsch, Sadhana Kannan, Shashikant Juvekar, Nikhil Merchant, Sridhar Epari, Aliasgar Moiyadi, Prakash Shetty, Goda Jayant Sastri, Rakesh Jalali
March-April 2018, 1(2):50-58
DOI:10.4103/glioma.glioma_12_18  
  928 147 -
BRAF mutation marks out specific subgroups of glioma
Aden Ka-Yin Chan, Riki Rui-Qi Zhang, Abudumijiti Aibaidula, Zhi Feng Shi, Hong Chen, Ying Mao, Ho Keung Ng
September-October 2018, 1(5):168-174
DOI:10.4103/glioma.glioma_33_18  
  887 181 -
Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma
Steven Lehrer, Peter H Rheinstein, Kenneth E Rosenzweig
July-August 2018, 1(4):132-135
DOI:10.4103/glioma.glioma_17_18  
  842 165 -
REVIEWS
Combination of oncolytic viruses and immune checkpoint inhibitors in glioblastoma
Kunal Desai, Anne Hubben, Manmeet Ahluwalia
January-March 2019, 2(1):7-19
DOI:10.4103/glioma.glioma_5_19  
  899 105 -
EDITORIAL
Preface from Editor-in-Chief
Zhong-Ping Chen
January-February 2018, 1(1):1-1
DOI:10.4103/glioma.glioma_7_18  
  817 174 -
ORIGINAL ARTICLES
The delta-like ligand 4-notch signaling inhibits tumor angiogenesis but promotes tumor growth in primary glioblastoma: An immunohistochemical study
Yao Chen, Zhi-Xiong Lin, Jin-Tao Chen, Ming-Cheng Zheng
March-April 2018, 1(2):59-65
DOI:10.4103/glioma.glioma_11_18  
  873 118 -
Expression and tumor-promoting effects of caprin-1 in human glioma
Li Zhang, Hui Gui, Xiang-Jun Tang, Zhuo-Shun Yang, Dan-Dan Zou, Jun-Ti Lu, Li-Dong Yan, Long-Jun Dai, Jie Luo, Bin Wang
July-August 2018, 1(4):136-141
DOI:10.4103/glioma.glioma_29_18  
  824 146 -
REVIEWS
Nanoparticles drug-delivery systems and antiangiogenic approaches in the treatment of gliomas
Maria Caffo, Salvatore Massimo Cardali, Elena Fazzari, Valeria Barresi, Gerardo Caruso
November-December 2018, 1(6):183-188
DOI:10.4103/glioma.glioma_43_18  
  791 153 -
ORIGINAL ARTICLES
Be cautious to bid farewell to GBMO: evidence from a propensity score analysis
Haihui Jiang, Yong Cui, Xiaohui Ren, Song Lin
January-February 2018, 1(1):27-33
DOI:10.4103/glioma.glioma_8_17  
  819 118 -
EDITORIAL
The times they are a-changin' – How molecular pathology will change practice
Ho-Keung Ng
September-October 2018, 1(5):147-148
DOI:10.4103/glioma.glioma_32_18  
  716 213 -
ORIGINAL ARTICLES
Clinical and magnetic resonance imaging features of spinal cord glioblastoma multiforme in a series of 12 cases: A single-institutional experience
Fuyou Guo, Guoqing Wang, Vigneyshwar Suresh, Dingkang Xu, Xiaoyang Zhang, Mengzhao Feng, Fang Wang, Xianzhi Liu, Laijun Song
May-June 2018, 1(3):111-116
DOI:10.4103/glioma.glioma_25_18  
  795 126 -